Back to Search
Start Over
Characterisation of malignant peripheral nerve sheath tumours in neurofibromatosis-1 using heterogeneity analysis of 18 F-FDG PET.
- Source :
-
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2017 Oct; Vol. 44 (11), pp. 1845-1852. Date of Electronic Publication: 2017 Jun 07. - Publication Year :
- 2017
-
Abstract
- Purpose: Measurement of heterogeneity in <superscript>18</superscript> F-fluorodeoxyglucose ( <superscript>18</superscript> F-FDG) positron emission tomography (PET) images is reported to improve tumour phenotyping and response assessment in a number of cancers. We aimed to determine whether measurements of <superscript>18</superscript> F-FDG heterogeneity could improve differentiation of benign symptomatic neurofibromas from malignant peripheral nerve sheath tumours (MPNSTs).<br />Methods: <superscript>18</superscript> F-FDG PET data from a cohort of 54 patients (24 female, 30 male, mean age 35.1 years) with neurofibromatosis-1 (NF1), and clinically suspected malignant transformation of neurofibromas into MPNSTs, were included. Scans were performed to a standard clinical protocol at 1.5 and 4 h post-injection. Six first-order [including three standardised uptake value (SUV) parameters], four second-order (derived from grey-level co-occurrence matrices) and four high-order (derived from neighbourhood grey-tone difference matrices) statistical features were calculated from tumour volumes of interest. Each patient had histological verification or at least 5 years clinical follow-up as the reference standard with regards to the characterisation of tumours as benign (n = 30) or malignant (n = 24).<br />Results: There was a significant difference between benign and malignant tumours for all six first-order parameters (at 1.5 and 4 h; p < 0.0001), for second-order entropy (only at 4 h) and for all high-order features (at 1.5 h and 4 h, except contrast at 4 h; p < 0.0001-0.047). Similarly, the area under the receiver operating characteristic curves was high (0.669-0.997, p < 0.05) for the same features as well as 1.5-h second-order entropy. No first-, second- or high-order feature performed better than maximum SUV (SUVmax) at differentiating benign from malignant tumours.<br />Conclusions: <superscript>18</superscript> F-FDG uptake in MPNSTs is higher than benign symptomatic neurofibromas, as defined by SUV parameters, and more heterogeneous, as defined by first- and high-order heterogeneity parameters. However, heterogeneity analysis does not improve on SUVmax discriminative performance.
- Subjects :
- Adolescent
Adult
Aged
Child
Diagnosis, Differential
Female
Humans
Limit of Detection
Male
Middle Aged
Nerve Sheath Neoplasms pathology
Neurofibromatosis 1 pathology
Positron Emission Tomography Computed Tomography methods
Fluorodeoxyglucose F18
Nerve Sheath Neoplasms diagnostic imaging
Neurofibromatosis 1 diagnostic imaging
Positron Emission Tomography Computed Tomography standards
Radiopharmaceuticals
Subjects
Details
- Language :
- English
- ISSN :
- 1619-7089
- Volume :
- 44
- Issue :
- 11
- Database :
- MEDLINE
- Journal :
- European journal of nuclear medicine and molecular imaging
- Publication Type :
- Academic Journal
- Accession number :
- 28589254
- Full Text :
- https://doi.org/10.1007/s00259-017-3733-1